PATH
Menu

These fact sheets describe PATH's pilot introduction project to deliver the injectable contraceptive Sayana® Press (depot medroxyprogesterone acetate or DMPA) to women in sub-Saharan Africa and South Asia. The fact sheets also provide clinical information about Sayana® Press.

Corporate author(s): PATH

Publication date: 2013

Available materials

English

Sayana® Press: Pilot Introduction and Evaluation

565 KB PDF

Hard copies are not available.

Sayana® Press Clinical Brief

173 KB PDF

Hard copies are not available.

French

Sayana® Press: Pilot Introduction and Evaluation [French]

204 KB PDF

Also known as: Sayana® Press : L’Introduction et Évaluation Initiale

Hard copies are not available.

Sayana® Press Clinical Brief [French]

295 KB PDF

Also known as: Sayana® Press Dossier Clinique

Hard copies are not available.

Frequently Asked Questions About Sayana® Press and Subcutaneous DMPA [French]

128 KB PDF

Also known as: Questions Fréquentes Concernant Sayana® Press et DMPA Sous-cutané

Hard copies are not available.

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

Region: Global

See also: Reproductive healthFamily planning

For more information…

Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA